| 1 | 2756-25-4 | 3,3-dimethoxy-2,4(1H,3H)-quinolinedione | C11H11NO4 | 221.20934 | | |
| 2 | 2756-52-7 | Cyclopropanecarboxylicacid, 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-, 2,3,4,5,6-pentachlorophenylester | C16H15Cl5O2 | 416.5541 | | |
| 3 | 2756-56-1 | Isobornyl propionate | C13H22O2 | 210.31 | | 19.8mg/L at 24℃ |
| 4 | 2756-68-5 | Imidodicarbonicdiamide, N,2-dimethyl-N'-phenyl- | C10H13N3O2 | 207.22912 | | |
| 5 | 2756-75-4 | 4-AMINO-3-NITROAZOBENZENE | C12H10N4O2 | 242.23 | | |
| 6 | 2756-76-5 | ethenyl 2-(1,3-dioxoisoindol-2-yl)acetate | C12H9NO4 | 231.2 | 104-105 °C(Solv: ligroine (8032-32-4)) | |
| 7 | 2756-79-8 | 2,6-Di-tert-butyl-4-methyl-4-allyl-cyclohexa-2,5-dien-1-one | C18H28O | 260.41 | | |
| 8 | 2756-85-6 | 1-Amino-1-cyclohexanecarboxylic acid | C7H13NO2 | 143.18 | >300°C(lit.) | almost transparency |
| 9 | 2756-87-8 | Monomethyl fumarate | C5H6O4 | 130.1 | 144-145 °C (lit.) | |
| 10 | 2756-89-0 | 3,4,5,6-tetrahydropyridine-2-carboxylic acid | C6H9NO2 | 127.14 | 93 °C | |
| 11 | 2756-91-4 | L-THIOPROLINE | | | | |
| 12 | 2756-97-0 | INDOLE-3-ACRYLIC ACIDMETHYL ESTER (IAcrAMe) | C12H11NO2 | 201.22 | | |
| 13 | 27560-04-9 | 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(β-D-galactopyranosyloxy)-5,7-dihydroxy-8-methoxy- | C22H22O13 | 494.4 | | |
| 14 | 27560-18-5 | L-Cysteine, N,S-bis(triphenylmethyl)-, 2,5-dioxo-1-pyrrolidinyl ester | C45H38N2O4S | 702.86 | | |
| 15 | 27560-30-1 | dimethyloctadecyl[2-(octadecyloxy)-2-oxoethyl]ammonium chloride | C40H82ClNO2 | 644.53758 | | |
| 16 | 27560-48-1 | 2,2'-[(dimethylsilylene)bis(oxy)]bisethanol | C6H16O4Si | 180.27 | | |
| 17 | 2756001-39-3 | Luvesilocin | | | | |
| 18 | 2756001-75-7 | Elsunersen | | | | |
| 19 | 2756011-83-1 | 2756011-83-1 | C15H22O4 | 266.33 | | |
| 20 | 2756014-24-9 | Imidazo[1,2-a]pyrimidine, 3-(4-chloro-2-methoxyphenyl)-1,5,6,7-tetrahydro-1-(2'-methoxy[1,1'-biphenyl]-4-yl)- | C26H24ClN3O2 | 445.94 | | |
| 21 | 2756014-25-0 | IGUANA-1 formate | | | | |
| 22 | 2756016-53-0 | Heterophdoid A | C26H42O10 | 514.61 | | |
| 23 | 2756018-87-6 | potassium trifluoro(2,3,4-trifluoro-6-hydroxyphenyl)borate | | | | |
| 24 | 2756027-80-0 | 2,12-diethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,9-dioxa-13bboranaphtho[3,2,1-de]anthracene | C28H30B2O4 | 452.16 | | |
| 25 | 2756090-53-4 | 1-Piperidinecarboxylic acid, 4-ethoxy-2-[4-(methoxycarbonyl)phenyl]-, phenylmethyl ester, (2R,4R)-rel- | C23H27NO5 | 397.46 | | |
| 26 | 2756091-64-0 | 2,6-Piperidinedione, 1-[(1E)-2-phenylethenyl]- | C13H13NO2 | 215.25 | | |
| 27 | 2756096-11-2 | 8-(3,5-di-tert-butylphenyl)-1,4-dioxaspiro[4.5]decan-8-ol | C22H34O3 | 346.51 | | |
| 28 | 2756096-23-6 | α,α-Bis(1-methylethyl)-4-(phenylmethoxy)benzenemethanol | C20H26O2 | 298.43 | | |
| 29 | 2756099-59-7 | 4-Piperidinecarboxamide, N-[4-(2-benzothiazolyl)phenyl]-1-[(2-chlorophenyl)sulfonyl]- | C25H22ClN3O3S2 | 512.04 | | |
| 30 | 27561-41-7 | α-(1,1-Dimethylethyl)-α,2-dimethylbenzenemethanol | | | | |
| 31 | 27561-50-8 | 1-bromo-2-(bromomethyl)-4-methylbenzene | C8H8Br2 | 263.95712 | | |
| 32 | 27561-51-9 | 1-Bromo-4-(bromomethyl)-2-methylbenzene | C8H8Br2 | 263.96 | 26-27 °C | |
| 33 | 27561-52-0 | 4-Methyl-2-(N,N-dimethylaminomethyl)bromobenzene | C10H14BrN | 228.13 | | |
| 34 | 27561-53-1 | Benzenemethanamine, 4-bromo-N,N,3-trimethyl- | C10H14BrN | 228.13 | | |
| 35 | 27561-62-2 | 1-(Cyclohexylcarbonyl)piperazine | C11H20N2O | 196.29 | 84-89 °C (lit.) | |
| 36 | 27561-78-0 | N-4-AMINOBUTYL-3-AMINOPROPIONIC ACID SULFATE SALT | C7H18N2O6S | 258.29 | | |
| 37 | 2756125-46-7 | Formamide, N-hydroxy-N-[(1S)-1-(methylthio)-2-[5-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]-1H-benzotriazol-1-yl]ethyl]- | C23H25N5O3S | 451.54 | | |
| 38 | 2756163-62-7 | 2,6-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | C12H15BF2O3 | 256.06 | | |
| 39 | 2756173-91-6 | Carbonic acid, (1R,2E,6S,10E,11aS,13S,14aR)-1,6,7,8,9,11a,12,13,14,14a-decahydro-1-hydroxy-6-methyl-4-oxo-4H-cyclopent[f]oxacyclotridecin-13-yl 3-pyridinylmethyl ester | C23H29NO6 | 415.48 | | |
| 40 | 27562-78-3 | Hydrazinecarbothioamide,2-(4-chlorophenyl)-N-methyl- | C8H10ClN3S | 215.7031 | | |
| 41 | 2756214-40-9 | Benzamide, N-(trans-4-hydroxycyclohexyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- | C19H28BNO4 | 345.24 | | |
| 42 | 2756218-99-0 | Enpp-1-IN-15 | | | | |
| 43 | 2756222-40-7 | 1,3-Benzenedicarbonyl dichloride, 5-amino-4-chloro-2,6-diiodo- | C8H2Cl3I2NO2 | 504.27 | | |
| 44 | 2756222-41-8 | Iopromide Impurity 44 | C8H2Cl3I2NO2 | 504.27 | | |
| 45 | 2756222-42-9 | dimethyl 5-amino-4-chloroisophthalate | | | | |
| 46 | 2756222-50-9 | 5-amino-4-chloroisophthalic acid | | | | |
| 47 | 2756222-51-0 | 5-amino-4-chloro-2,6-diiodoisophthalic acid | C8H4ClI2NO4 | 467.38 | | |
| 48 | 2756222-90-7 | HY-078020 | C32H35ClN2O2 | 515.09 | | |
| 49 | 2756228-76-7 | Riliprubart | | | | |
| 50 | 2756228-84-7 | Zovostotug | | | | |
| 51 | 2756235-94-4 | 1H-Indazole-1,3-dicarboxylic acid, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,3-bis(1,1-dimethylethyl) ester | C23H33BN2O6 | 444.33 | | |
| 52 | 2756246-93-0 | methyl 5-chloro-6-cyclopropylpicolinate | C10H10ClNO2 | 211.65 | | |
| 53 | 2756250-30-1 | 5-Oxazolidinecarboxamide, N-[(S)-(4-chlorophenyl)[4-chloro-3-(trifluoromethyl)phenyl]methyl]-2-oxo-, (5S)- | C18H13Cl2F3N2O3 | 433.21 | | |
| 54 | 2756257-56-2 | Benzamide, N-[4-methyl-3-[8-methyl-2-[(2,3,4,5-tetrahydro-3,5-dimethyl-1H-3-benzazepin-7-yl)amino]-6-quinazolinyl]phenyl]-3-(trifluoromethyl)- | C36H34F3N5O | 609.68 | | |
| 55 | 2756262-59-4 | 8-bromo-2',3',5',6'-tetrahydro-5-[(methylthio)methyl]-spiro[1,5-benzoxazepine-2(3H),4'-[4H]pyran]-4(5H)-one | C15H18BrNO3S | 372.28 | | |
| 56 | 2756277-32-2 | spiro[fluorene-9,9'-xanthen]-2'-amine | C25H17NO | 347.42 | | |
| 57 | 27563-14-0 | 1-(ACETYLAMINO)-4-BROMOANTHRAQUINONE | C16H10BrNO3 | 344.16 | | |
| 58 | 27563-26-4 | 4-[3-(1-Naphtyl)butyl]morpholine | C18H23NO | 269.38 | | |
| 59 | 27563-60-6 | 2-CYCLOHEXYLACETOHYDRAZIDE | C8H16N2O | 156.23 | | |
| 60 | 27563-65-1 | 3-chlorophthalic acid | C8H5ClO4 | 200.58 | | 21.2g/L(14 ºC) |
| 61 | 27563-67-3 | N-Methyldodecanamide | C13H27NO | 213.36 | 67-68°C | |
| 62 | 27563-68-4 | HEXADECYL METHYL SULFIDE | C17H36S | 272.53 | 7.75°C (estimate) | |
| 63 | 27563-96-8 | Benzoic acid, 3,5-dinitro-, 4-Methylphenyl ester | C14H10N2O6 | 302.24 | | |
| 64 | 2756307-49-8 | Butanoic acid, 4-[[(1S)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-, sodium salt (1:1) | C32H31F5N3NaO5 | 655.6 | | |
| 65 | 2756307-50-1 | 2,4(1H,3H)-Pyrimidinedione, 3-[(2S)-2-amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl- | C28H24F5N3O3 | 545.5 | | |
| 66 | 2756314-06-2 | Ethyl 2-(2-azaspiro[3.3]heptan-6-yl)acetate 2,2,2-trifluoroacetate | C12H18F3NO4 | 297.27 | | |
| 67 | 2756317-31-2 | 2,6-Piperidinedione, 3-[3-fluoro-4-(4-piperidinyl)phenyl]- | C16H19FN2O2 | 290.33 | | |
| 68 | 2756317-74-3 | 1-Piperidinecarboxylic acid, 4-(5-hydroxy-2-pyridinyl)-, 1,1-dimethylethyl ester | C15H22N2O3 | 278.35 | | |
| 69 | 2756318-16-6 | 2H-Benzimidazol-2-one, 1-[2,6-bis(phenylmethoxy)-3-pyridinyl]-5-bromo-1,3-dihydro-3-methyl- | C27H22BrN3O3 | 516.39 | | |
| 70 | 2756319-96-5 | Naphthalene, 2-(2-chloro[1,1'-biphenyl]-4-yl)- | C22H15Cl | 314.81 | | |
| 71 | 2756323-15-4 | MS934 | C52H69F3IN7O6S | 1104.12 | | |
| 72 | 2756323-28-9 | MS910 | C41H48F3IN6O11 | 984.75 | | |
| 73 | 2756327-67-8 | ERGi-USU-6 mesylate | | | | |
| 74 | 2756333-39-6 | 2-Pyridinecarboxamide, 6-fluoro-5-[4-[(5-fluoro-3,4-dihydro-2-methyl-3-oxo-6-quinoxalinyl)methyl]-1-piperazinyl]-N-methyl- | C21H22F2N6O2 | 428.44 | | |
| 75 | 2756333-42-1 | AZ3391 | C23H27FN6O2 | 438.5 | | |
| 76 | 2756333-88-5 | 2-Pyridinecarboxylic acid, 6-fluoro-5-(1-piperazinyl)-, methyl ester | C11H14FN3O2 | 239.25 | | |
| 77 | 2756333-93-2 | 2(1H)-Quinoxalinone, 7-(bromomethyl)-8-fluoro-3-methyl- | C10H8BrFN2O | 271.09 | | |
| 78 | 2756334-24-2 | 7-bromo-8-fluoro-3-methyl-3,4-dihydroquinoxalin-2(1H)-one | C9H8BrFN2O | 259.08 | | |
| 79 | 2756334-26-4 | 7-Bromo-8-fluoro-3-methylquinoxalin-2(1H)-one | C9H6BrFN2O | 257.06 | | |
| 80 | 2756334-27-5 | 2(1H)-Quinoxalinone, 8-fluoro-7-(hydroxymethyl)-3-methyl- | C10H9FN2O2 | 208.19 | | |
| 81 | 2756334-30-0 | 7-Bromo-3-ethyl-8-fluoro-3,4-dihydro-2(1H)-quinoxalinone | C10H10BrFN2O | 273.1 | | |
| 82 | 2756334-31-1 | 7-bromo-3-ethyl-8-fluoro-1H-quinoxalin-2-one | C10H8BrFN2O | 271.09 | | |
| 83 | 2756334-32-2 | 2(1H)-Quinoxalinone, 3-ethyl-8-fluoro-7-(hydroxymethyl)- | C11H11FN2O2 | 222.22 | | |
| 84 | 2756334-33-3 | 2(1H)-Quinoxalinone, 7-(bromomethyl)-3-ethyl-8-fluoro- | C11H10BrFN2O | 285.11 | | |
| 85 | 2756334-41-3 | 8-Fluoro-7-(hydroxymethyl)-3-methoxyquinoxalin-2(1H)-one | | | | |
| 86 | 2756337-15-0 | 2-(4,4-Difluorocyclohexyl)-3-methoxy-3-oxopropanoic acid | C10H14F2O4 | 236.21 | | |
| 87 | 2756337-27-4 | PARP1-IN-19 | | | | |
| 88 | 2756347-91-6 | 3-Pyridinemethanol, 6-(2-hydroxy-2-methylpropoxy)-5-[4-(methylsulfonyl)phenyl]-2-propoxy- | C20H27NO6S | 409.5 | | |
| 89 | 2756350-91-9 | Benzamide, 2-methyl-N-[2-methyl-4-[[[(1R)-1-(1-methyl-4-piperidinyl)ethyl]amino]sulfonyl]phenyl]- | C23H31N3O3S | 429.58 | | |
| 90 | 2756350-98-6 | Benzamide, N-[2-chloro-6-methyl-4-[[[(1R)-1-(1-methyl-4-piperidinyl)ethyl]amino]sulfonyl]phenyl]-2-methyl- | C23H30ClN3O3S | 464.02 | | |
| 91 | 2756367-23-2 | 1-(5-(2-Fluorophenyl)-4-methoxy-1-((6-methoxypyridin-3-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | C19H20FN3O4S | 405.45 | | |
| 92 | 2756367-24-3 | 5-(2,4-Difluorophenyl)-4-methoxy-1-[(6-methoxy-3-pyridinyl)sulfonyl]-N-methyl-1H-pyrrole-3-methanamine | C19H19F2N3O4S | 423.44 | | |
| 93 | 2756367-25-4 | 5-(2,4-Difluorophenyl)-4-methoxy-N-methyl-1-[(6-methyl-3-pyridinyl)sulfonyl]-1H-pyrrole-3-methanamine | C19H19F2N3O3S | 407.44 | | |
| 94 | 2756367-27-6 | Fexuprazan Impurity 43 | | | | |
| 95 | 2756368-79-1 | AChE/BChE-IN-21 | C38H54N4O4 | 630.86 | | |
| 96 | 2756369-67-0 | 5,8-Bis(2,4-dimethylphenyl)-2-(2,2,2-trifluoroethoxy)-1,3,3a1,4,6,7,9-heptaazaphenalene | C24H20F3N7O | 479.46 | | |
| 97 | 2756380-41-1 | Thieno[2,3-d]pyrimidine, 4-chloro-2-[1-(2-methoxyethyl)-1H-imidazol-2-yl]- | C12H11ClN4OS | 294.76 | | |
| 98 | 2756380-46-6 | ethyl 4-hydroxy-7-(pyridin-2-yl)thieno[3,2-d]pyrimidine-2-carboxylate | | | | |
| 99 | 2756380-51-3 | 6-(1-isopropyl-1H-pyrazol-3-yl)-5-methyl-2-(pyridin-2-yl)thieno[2,3-d]pyrimidin-4-ol | | | | |
| 100 | 2756383-24-9 | SOX11 inhibitor Compound R (SOX11i) | C22H19N3O4S2 | 453.53 | | |
| 101 | 27564-01-8 | 2-mercaptoethyl stearate | C20H40O2S | 344.6 | | |
| 102 | 27564-02-9 | 5-chloro-2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride | C23H25Cl2N3 | 414.3707 | | |
| 103 | 27564-03-0 | 1,3,3-trimethyl-2-[[(2-nitrophenyl)hydrazono]methyl]-3H-indolium chloride | C18H19ClN4O2 | 358.82206 | | |
| 104 | 2756408-46-3 | 1-(4-bromonaphthalen-1-yl)cyclopentanol | C15H15BrO | 291.19 | | |
| 105 | 2756408-47-4 | 1-(4-bromonaphthalen-1-yl)cyclobutanol | C14H13BrO | 277.16 | | |
| 106 | 2756410-57-6 | Benzamide, 2-chloro-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-methoxy- | C14H10ClN3O4 | 319.7 | | |
| 107 | 2756410-83-8 | 3-Piperidinecarboxylic acid, 1-[3-methoxy-4-[[[5-(2-thienyl)-1,3,4-oxadiazol-2-yl]amino]carbonyl]phenyl]- | C20H20N4O5S | 428.46 | | |
| 108 | 2756414-41-0 | 2(1H)-Pyridinone, 5-(1,1-difluoroethyl)- | C7H7F2NO | 159.13 | | |
| 109 | 2756414-42-1 | 1-[[2,2-difluoro-2-[1,1,2,2-tetrafluoro-2-(1,1,2,2,2-pentafluoroethoxy)ethoxy]ethoxy]methyl]-4-ethenyl- benzene, | | | | |
| 110 | 2756414-77-2 | Antimalarial agent 7 | | | | |
| 111 | 2756439-73-1 | 4-(benzo[b]thiophen-2-yl)-N-(4-(benzo[d]oxazol-2-yl)phenyl)aniline | C27H18N2OS | 418.51 | | |
| 112 | 2756441-34-4 | 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-, 1-methylethyl ester, (6E)- | C27H30FNO4 | 451.53 | | |
| 113 | 2756458-55-4 | 2(1H)-Quinolinone, 1-(2-chlorophenyl)-4-(methylamino)-7-(trifluoromethyl)- | C17H12ClF3N2O | 352.74 | | |
| 114 | 2756458-72-5 | 1,8-Naphthyridine-3-carboxylic acid, 1-(2-chlorophenyl)-1,2-dihydro-4-(methylamino)-2-oxo-7-(trifluoromethyl)-, methyl ester | C18H13ClF3N3O3 | 411.76 | | |
| 115 | 2756458-77-0 | 1,8-Naphthyridin-2(1H)-one, 1-(2-chlorophenyl)-3-methoxy-4-(methylamino)-7-(trifluoromethyl)- | C17H13ClF3N3O2 | 383.75 | | |
| 116 | 2756465-66-2 | DOTA-PEG4-MeTz | C33H51N9O11 | 749.81 | | |
| 117 | 27565-66-8 | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-amino-7-oxo-, | C6H8N2O3S | 188.2 | | |
| 118 | 27565-67-9 | (6R)-3,3-Didemethyl-6-[(phenoxyacetyl)amino]penicillanic acid | C14H14N2O5S | 322.34 | | |
| 119 | 27565-92-0 | 1,1'-Biphenyl,3-(methylthio)-4-nitro- | C13H11NO2S | 245.29694 | | |
| 120 | 2756557-83-0 | β-Alanine, N-[2-(5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-, (1R)-1-[(2R,3S)-2-(carboxymethyl)-1-[[(2-methylphenyl)amino]carbonyl]-4-oxo-3-azetidinyl]ethyl ester | C24H26FN5O9 | 547.49 | | |
| 121 | 2756559-71-2 | 1H-Pyrrole-1-propanol, β-(fluoromethylene)-2,5-dimethyl-, (βE)- | C10H14FNO | | | |
| 122 | 2756566-45-5 | UZH2 | C27H37F2N7O | 513.64 | | |
| 123 | 2756566-57-9 | 2,5,8-Triazaspiro[3.5]nonane-2-carboxylic acid, 6-oxo-, 1,1-dimethylethyl ester | C11H19N3O3 | 241.29 | | |
| 124 | 2756581-13-0 | Cyclohexanecarboxylic acid, 2-[(phenylamino)carbonyl]-, (1R,2S)- | C14H17NO3 | 247.29 | | |
| 125 | 2756581-81-2 | IDOR-1104-0086 | | | | |
| 126 | 2756589-62-3 | 2-Pyridinamine, 4-(1,4-dimethyl-1H-pyrazol-5-yl)-6-[(3R)-3-methyl-4-morpholinyl]-N-(5-methyl-1H-pyrazol-3-yl)- | C19H25N7O | 367.45 | | |
| 127 | 2756589-94-1 | (S)-1-Thia-6-azaspiro[3.5]nonane 1,1-dioxide hydrochloride | C7H14ClNO2S | 211.7 | | |
| 128 | 2756590-35-7 | 2,6-Dichloro-3-fluoro-4-iodopyridine | C5HCl2FIN | 291.88 | | |
| 129 | 2756590-39-1 | 2,6-Dichloro-3-fluoro-4-((methylsulfonyl)methyl)pyridine | C7H6Cl2FNO2S | 258.09 | | |
| 130 | 2756592-19-3 | Difelikefalin Impurity 9 Trifluoroacetate | C37H55N7O6 | 693.88 | | |
| 131 | 2756594-27-9 | 1H-Benzimidazole-6-carboxamide, 2-(2-fluoro-3,4-dihydroxy-5-methoxyphenyl)-1-(3-methyl-3-oxetanyl)- | C19H18FN3O5 | 387.36 | | |
| 132 | 27566-05-8 | 4-[2-[(phenylmethyl)amino]propyl]- Phenol | C16H19NO | 241.33 | | |
| 133 | 27566-09-2 | Levothyroxine Sodium impurity | C14H21NO4 | 267.32 | | |
| 134 | 27566-30-9 | 4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(methoxymethyl)phenol hydrochloride | C14H24ClNO3 | 289.8 | | |
| 135 | 27566-35-4 | 4-Morpholinebutanamine,b-[2-(4-morpholinyl)ethyl]-b-1-naphthalenyl- | C24H35N3O2 | 397.5536 | | |
| 136 | 27566-36-5 | 1,5-Pentanediamine,N5,N5,2-trimethyl-2-(1-naphthalenyl)- | C18H26N2 | 270.41244 | | |
| 137 | 27566-41-2 | 1-Piperidinepentanamine,b-(1-methylethyl)-b-1-naphthalenyl- | C23H34N2 | 338.53 | | |
| 138 | 27566-42-3 | 1-Piperidinepentanamine,b-(1-methylpropyl)-b-1-naphthalenyl- | C24H36N2 | 352.55604 | | |
| 139 | 27566-44-5 | 4-Morpholinepentanamine,b-(1-methylpropyl)-b-1-naphthalenyl- | C23H34N2O | 354.52886 | | |
| 140 | 27566-46-7 | 1,6-Hexanediamine,N6,N6-dimethyl-2-(1-methylpropyl)-2-(1-naphthalenyl)- | C22H34N2 | 326.52 | | |
| 141 | 27566-48-9 | 1-Pyrrolidinehexanamine,b-(1-methylpropyl)-b-1-naphthalenyl- | C24H36N2 | 352.55604 | | |
| 142 | 27566-49-0 | 1-Piperidinehexanamine,b-(1-methylethyl)-b-1-naphthalenyl- | C24H36N2 | 352.55604 | | |
| 143 | 27566-50-3 | 1-Piperidinehexanamine,b-(1-methylpropyl)-b-1-naphthalenyl- | C25H38N2 | 366.58262 | | |
| 144 | 27566-51-4 | 4-Morpholinehexanamine,b-(1-methylethyl)-b-1-naphthalenyl- | C23H34N2O | 354.52886 | | |
| 145 | 27566-54-7 | 4-Morpholinehexanamine,b-(1-methylpropyl)-b-1-naphthalenyl- | C24H36N2O | 368.55544 | | |
| 146 | 27566-60-5 | 1,4-Butanediamine,N4,N4-dimethyl-2-(1-methylpropyl)-2-(1-naphthalenylmethyl)- | C21H32N2 | 312.49 | | |
| 147 | 27566-61-6 | 1-Piperidinebutanamine,b-(1-methylethyl)-b-(1-naphthalenylmethyl)- | C23H34N2 | 338.52946 | | |
| 148 | 27566-62-7 | 1-Piperidinebutanamine,b-(1-methylpropyl)-b-(1-naphthalenylmethyl)- | C24H36N2 | 352.55604 | | |
| 149 | 27566-63-8 | Cyanamide,[2-(11-hydroxy-10-methoxyphenanthro[3,4-d]-1,3-dioxol-5-yl)ethyl]methyl-,acetate (ester) (8CI) | C22H20N2O5 | 392.4046 | | |
| 150 | 27566-65-0 | Cyanamide, [2-(5,6-dihydroxy-1-phenanthryl)ethyl]methyl- (8CI) | C18H16N2O2 | 292.33 | | |
| 151 | 27566-66-1 | Cyanamide,N-methyl-N-(2-phenylethyl)- | C10H12N2 | 160.21568 | | |
| 152 | 2756653-45-7 | 6-Amino-4-bromoisoindolin-1-one | C8H7BrN2O | 227.06 | | |
| 153 | 2756657-02-8 | 4,6-Dichloro-3-cyclopropyl-1H-pyrazolo[4,3-c]pyridine | C9H7Cl2N3 | 228.08 | | |
| 154 | 2756661-48-8 | INDEX NAME NOT YET ASSIGNED | C25H32N4O8 | 516.54 | | |
| 155 | 2756665-52-6 | Imidazo[1,5-a]pyrimidine, 6-methyl-4-[(3R)-3-methyl-4-morpholinyl]-2-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)- | C19H22N8O | 378.43 | | |
| 156 | 2756668-73-0 | 1-Piperazinecarboxamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-4-[6-[4-(4-methyl-1-piperazinyl)phenyl]thieno[2,3-d]pyrimidin-4-yl]- | C29H29ClF3N7OS | 616.1 | | |
| 157 | 2756668-88-7 | 6-(4-(4-methylpiperazin-1-yl)phenyl)-4-(piperazin-1-yl)thieno[2,3-d]pyrimidine | | | | |
| 158 | 2756674-96-9 | N,N′-bis(ethylhexyl)-1,7-dibromo-3,4:9,10-perylenetetracarboxylic diimide | C40H40Br2N2O4 | 772.58 | | |
| 159 | 2756689-44-6 | 1-(3,5-Bis(trifluoromethyl)phenyl)-3-((S)-1-((R)-2-(4-chlorophenyl)-2-methylpyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)thiourea | C26H28ClF6N3OS | 580.03 | | |
| 160 | 2756696-54-3 | 3-Cyclohexen-1-one, 3-[(4S,5S)-5-[(1S,6S)-2-(hydroxymethyl)-1,3-dimethyl-6-(phenylmethoxy)-2-cyclohexen-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2,4-trimethyl- | C30H42O5 | 482.65 | | |
| 161 | 27567-10-8 | CASSIAMINB | C30H18O10 | 538.46 | | |
| 162 | 27567-11-9 | CASSIAMINC | C30H18O8 | 506.46 | | |
| 163 | 27567-76-6 | 1,4-Cycloundecanedione | C11H18O2 | 182.26 | | |
| 164 | 27567-82-4 | Cyclopropane cyclopropylidene- | C6H8 | 80.13 | 12℃ | |
| 165 | 27567-85-7 | 2,3,3a,5,6,7a-Hexahydro-2,5-methano-1H-inden-7(4H)-one | C10H14O | 150.22 | | |
| 166 | 2756700-87-3 | Ritlecitinib-d1B | | | | |
| 167 | 2756700-88-4 | Ritlecitinib-d1A | | | | |
| 168 | 2756700-89-5 | Ritlecitinib-d3A | | | | |
| 169 | 2756700-90-8 | Ritlecitinib-d3 | | | | |
| 170 | 2756700-91-9 | Ritlecitinib-d1 | | | | |
| 171 | 2756700-93-1 | Ritlecitinib-d2B | | | | |
| 172 | 2756700-95-3 | Ritlecitinib-d1C | | | | |
| 173 | 2756700-96-4 | Ritlecitinib-d2A | | | | |
| 174 | 2756700-97-5 | Ritlecitinib-d2 | | | | |
| 175 | 2756706-65-5 | 4H-Pyrimido[6',1':2,3]pyrimido[6,1-c][1,4]oxazin-4-one, 2-chloro-6,7,7a,8,10,11-hexahydro-, (7aS)- | C10H12ClN3O2 | 241.67 | | |
| 176 | 2756726-89-1 | 4-Isoquinolinol, 1-methyl-7-phenoxy- | C16H13NO2 | 251.28 | | |
| 177 | 2756739-00-9 | KRAS G12C inhibitor 32 | C29H30Cl3FN6O3 | 635.95 | | |
| 178 | 2756741-90-7 | | C38H42N12O10S2 | 890.94 | | |
| 179 | 2756742-40-0 | Phenol, 4-[[(2-fluorophenyl)imino]methyl]- | C13H10FNO | 215.22 | | |
| 180 | 2756774-27-1 | (4-butoxy-2,3-difluorophenyl)(butyl)sulfane | C14H20F2OS | 274.37 | | |
| 181 | 2756782-90-6 | Benzonitrile, 3-fluoro-4-[[[6-(4-piperidinyl)-2-pyridinyl]oxy]methyl]-, hydrochloride (1:1) | C18H19ClFN3O | 347.82 | | |
| 182 | 2756783-11-4 | 2-((4-chloro-2-fluorobenzyl)oxy)-6-(piperidin-4-yl)pyridine dihydrochloride | C17H19Cl2FN2O | 357.25 | | |
| 183 | 2756784-27-5 | 2,4'-Bipyridine, 6-[(4-chloro-2-fluorophenyl)methoxy]-1',2',3',6'-tetrahydro-, hydrochloride (1:1) | C17H17Cl2FN2O | 355.23 | | |
| 184 | 27568-04-3 | Ethyl 4-hydroxy-8-methoxyquinoline-3-carboxylate | C13H13NO4 | 247.25 | | |
| 185 | 27568-05-4 | Ethyl 4-Chloro-8-Methoxyquinoline-3-Carboxylate | C13H12ClNO3 | 265.70 | | |
| 186 | 27568-90-7 | TRIS(2-BROMOETHYL)PHOSPHATE | C6H12Br3O4P | 418.84 | | |
| 187 | 2756809-34-2 | Heptanamide, N-hydroxy-7-[(8-oxo-8H-phthalazino[1,2-b]quinazolin-5-yl)amino]- | C22H23N5O3 | 405.45 | | |
| 188 | 2756809-95-5 | 3-((6-(4-aminopiperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)-N-(3-chloro-5-(trifluoromethyl)phenyl)-2-methylbenzamide | | | | |
| 189 | 2756816-04-1 | (3-Amino-bicyclo[1.1.1]pent-1-yl)-acetonitrile hydrochloride | C7H11ClN2 | 158.63 | | |
| 190 | 2756818-39-8 | 2756818-39-8 | C17H18N4O2 | 310.36 | | |
| 191 | 2756820-80-9 | 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)azetidine hydrochloride | C15H22BNO3 | 275.15 | | |
| 192 | 2756820-87-6 | tert-butyl 3-[(5-bromopyrimidin-2-yl)amino]azetidine-1-carboxylate | | | | |
| 193 | 2756820-97-8 | 1H-Indazole-4-pentanoic acid, 1-(tetrahydro-2H-pyran-2-yl)-, ethyl ester | C19H26N2O3 | 330.42 | | |
| 194 | 2756820-98-9 | 1H-Indazole-4-pentanoic acid, 1-(tetrahydro-2H-pyran-2-yl)- | C17H22N2O3 | 302.37 | | |
| 195 | 2756821-14-2 | Butanoic acid, 4,4,4-trifluoro-2-[2-[[1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl]oxy]ethyl]- | C18H21F3N2O4 | 386.37 | | |
| 196 | 2756821-20-0 | 1H-Indazole-4-pentanoic acid, 1-(tetrahydro-2H-pyran-2-yl)-α-(2,2,2-trifluoroethyl)-, ethyl ester | C21H27F3N2O3 | 412.45 | | |
| 197 | 2756821-21-1 | 1H-Indazole-4-pentanoic acid, 1-(tetrahydro-2H-pyran-2-yl)-α-(2,2,2-trifluoroethyl)- | C19H23F3N2O3 | 384.39 | | |
| 198 | 2756821-51-7 | 1H-Indazole-4-pentanoic acid, 3-fluoro-1-(tetrahydro-2H-pyran-2-yl)-, ethyl ester | C19H25FN2O3 | 348.41 | | |
| 199 | 2756821-52-8 | 1H-Indazole-4-pentanoic acid, 3-fluoro-1-(tetrahydro-2H-pyran-2-yl)- | C17H21FN2O3 | 320.36 | | |
| 200 | 2756821-85-7 | Zotresiran | | | | |
| 201 | 2756837-91-7 | HIV-IN-1 | | | | |
| 202 | 2756838-41-0 | Hiv-IN-2 | C34H27ClF7N9O3S | 810.15 | | |
| 203 | 2756846-09-8 | 2-Propen-1-one, 3-[4-[[2-(dimethylamino)-5-pyrimidinyl]amino]phenyl]-1-(2,3,4-trihydroxyphenyl)-, (2E)- | C21H20N4O4 | 392.41 | | |
| 204 | 2756849-68-8 | 5H-1,4-Benzodiazepin-5-one, 1-ethyl-1,2,3,4-tetrahydro-4-[(2R)-2-hydroxy-2-[(3S)-1,2,3,4-tetrahydro-3-isoquinolinyl]ethyl]-8-[(2-methoxy-7-azaspiro[3.5]non-7-yl)carbonyl]- | C32H42N4O4 | 546.7 | | |
| 205 | 2756850-18-5 | 2,5-Dicarbonylpyrrolidin-1-yl 4-bromo-2-hydroxybenzoate | | | | |
| 206 | 2756851-99-5 | Acetamide, N-[3-chloro-4-(4-methyl-1-piperazinyl)phenyl]-2-[4-(3,4-dihydro-5,7-dimethoxy-4-oxo-2-quinazolinyl)phenoxy]- | C29H30ClN5O5 | 564.04 | | |
| 207 | 2756852-10-3 | tert-Butyl 2-(2,6-Dibromo-4-formylphenoxy)acetate | | | | |
| 208 | 2756855-45-3 | Lp-PLA2-IN-10 | | | | |
| 209 | 2756855-58-8 | 2,4-Dichloro-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine | C6H5Cl2N3O | 206.03 | | |
| 210 | 2756855-62-4 | Lp-PLA2-IN-13 | C22H17F5N4O4 | 496.39 | | |
| 211 | 2756855-66-8 | Lp-PLA2-IN-14 | | | | |
| 212 | 2756879-35-1 | Research Grade Xirestomig | | | | |
| 213 | 2756897-30-8 | N-(4-cyano-3-(trifluoromethyl)phenyl)-2-(4-((1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)azetidin-3-yl)ethynyl)-1H-pyrazol-1-yl)-2-methylpropanamide | C33H26F3N7O5 | 657.61 | | |
| 214 | 27569-09-1 | 3-methyl-4-(pyrrolidin-1-yl)benzenediazonium hexafluoroarsenate | C11H14AsF6N3 | 377.1609792 | | |
| 215 | 27569-10-4 | 4-pyrrolidinyl-m-toluenediazonium tetrachlorozincate (2:1) | C11H14Cl4N3Zn- | 395.43 | | |
| 216 | 27569-23-9 | ETHYL ACETATE, [1-14C] | C4H8O2 | 90.12 | | |
| 217 | 2756969-07-8 | Benzeneethanol, β-amino-3-fluoro-5-methoxy-α-methyl-, hydrochloride (1:1), (αS,βS)- | C10H14FNO2.ClH | 235.68 | | |
| 218 | 2756972-19-5 | 7,7-Difluoro-3,5-dihydro-4H-pyrimido[4,5-b][1,4]oxazine-4,6(7H)-dione | C6H3F2N3O3 | 203.1 | | |
| 219 | 2756972-24-2 | 5-Methyl-3,5,7,8-tetrahydropyrido[3,2-d]pyrimidine-4,6-dione | C8H9N3O2 | 179.18 | | |
| 220 | 2756973-32-5 | Palladium, [μ-[1,1'-(1,4-butanediyl)bis[1,1-bis(1,1-dimethylethyl)phosphine-κP]]]dichlorobis[(1,2,3-η)-1-phenyl-2-propen-1-yl]di- | C38H58Cl2P2Pd2 | 860.57 | | |
| 221 | 2756973-33-6 | Palladium, [μ-[1,1'-(1,4-butanediyl)bis[1,1-bis(1,1-dimethylethyl)phosphine-κP]]]dichlorobis(η3-2-propen-1-yl)di- | C26H50Cl2P2Pd2 | 708.37 | | |
| 222 | 2756973-34-7 | 2756973-34-7 | | | | |
| 223 | 2756973-35-8 | Palladium, [μ-[1,1'-(1,4-butanediyl)bis[1,1-bis(1,1-dimethylethyl)phosphine-κP]]]bis(methanesulfonato-κO)bis[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]di- | C48H74N2O6P2Pd2S2 | 1114.04 | | |
| 224 | 2756973-43-8 | 4,4'-([1,1'-biphenyl]-4,4'-diylbis(methylene))bis(thiomorpholine 1,1-dioxide) | C22H28N2O4S2 | | | |
| 225 | 2756978-82-0 | 2,4-Pyrimidinediamine, 5-bromo-N4-[2-(dimethylphosphinyl)-4-methylphenyl]-N2-[2-methoxy-5-methyl-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]- | C31H43BrN7O2P | 656.6 | | |
| 226 | 2756983-19-2 | Cannabisin P | C34H34N2O9 | 614.65 | | |
| 227 | 2756985-10-9 | tert-Butyl 3-(6-bromopyridin-2-yl)-3-oxopropanoate | | | | |
| 228 | 2756997-82-5 | Targeting the bacterial sliding clamp peptide 46 | C47H64N8O11 | 917.06 | | |